Risk factors for magnetic resonance imaging-detected patellofemoral and tibiofemoral cartilage loss during a six-month period: the joints on glucosamine study
- PMID: 22213129
- DOI: 10.1002/art.34353
Risk factors for magnetic resonance imaging-detected patellofemoral and tibiofemoral cartilage loss during a six-month period: the joints on glucosamine study
Abstract
Objective: To assess several baseline risk factors that may predict patellofemoral and tibiofemoral cartilage loss during a 6-month period.
Methods: For 177 subjects with chronic knee pain, 3T magnetic resonance imaging (MRI) of both knees was performed at baseline and followup. Knees were semiquantitatively assessed, evaluating cartilage morphology, subchondral bone marrow lesions, meniscal morphology/extrusion, synovitis, and effusion. Age, sex, and body mass index (BMI), bone marrow lesions, meniscal damage/extrusion, synovitis, effusion, and prevalent cartilage damage in the same subregion were evaluated as possible risk factors for cartilage loss. Logistic regression models were applied to predict cartilage loss. Models were adjusted for age, sex, treatment, and BMI.
Results: Seventy-nine subregions (1.6%) showed incident or worsening cartilage damage at followup. None of the demographic risk factors was predictive of future cartilage loss. Predictors of patellofemoral cartilage loss were effusion, with an adjusted odds ratio (OR) of 3.5 (95% confidence interval [95% CI] 1.3-9.4), and prevalent cartilage damage in the same subregion with an adjusted OR of 4.3 (95% CI 1.3-14.1). Risk factors for tibiofemoral cartilage loss were baseline meniscal extrusion (adjusted OR 3.6 [95% CI 1.3-10.1]), prevalent bone marrow lesions (adjusted OR 4.7 [95% CI 1.1-19.5]), and prevalent cartilage damage (adjusted OR 15.3 [95% CI 4.9-47.4]).
Conclusion: Cartilage loss over 6 months is rare, but may be detected semiquantitatively by 3T MRI and is most commonly observed in knees with Kellgren/Lawrence grade 3. Predictors of patellofemoral cartilage loss were effusion and prevalent cartilage damage in the same subregion. Predictors of tibiofemoral cartilage loss were prevalent cartilage damage, bone marrow lesions, and meniscal extrusion.
Trial registration: ClinicalTrials.gov NCT00377286.
Copyright © 2012 by the American College of Rheumatology.
Similar articles
-
The association of meniscal pathologic changes with cartilage loss in symptomatic knee osteoarthritis.Arthritis Rheum. 2006 Mar;54(3):795-801. doi: 10.1002/art.21724. Arthritis Rheum. 2006. PMID: 16508930
-
Patterns of Coexisting Lesions Detected on Magnetic Resonance Imaging and Relationship to Incident Knee Osteoarthritis: The Multicenter Osteoarthritis Study.Arthritis Rheumatol. 2015 Dec;67(12):3158-65. doi: 10.1002/art.39436. Arthritis Rheumatol. 2015. PMID: 26414125 Free PMC article.
-
Effect of oral glucosamine on joint structure in individuals with chronic knee pain: a randomized, placebo-controlled clinical trial.Arthritis Rheumatol. 2014 Apr;66(4):930-9. doi: 10.1002/art.38314. Arthritis Rheumatol. 2014. PMID: 24616448 Free PMC article. Clinical Trial.
-
Is running good or bad for your knees? A systematic review and meta-analysis of cartilage morphology and composition changes in the tibiofemoral and patellofemoral joints.Osteoarthritis Cartilage. 2023 Feb;31(2):144-157. doi: 10.1016/j.joca.2022.09.013. Epub 2022 Nov 17. Osteoarthritis Cartilage. 2023. PMID: 36402349 Review.
-
Use of imaging techniques to predict progression in osteoarthritis.Curr Opin Rheumatol. 2013 Jan;25(1):127-35. doi: 10.1097/BOR.0b013e32835a0fe1. Curr Opin Rheumatol. 2013. PMID: 23080226 Review.
Cited by
-
Dual-tissue transplantation versus osteochondral autograft transplantation in the treatment of osteochondral defects: a porcine model study.J Orthop Surg Res. 2023 Jul 5;18(1):481. doi: 10.1186/s13018-023-03964-6. J Orthop Surg Res. 2023. PMID: 37403163 Free PMC article.
-
Role of imaging for eligibility and safety of a-NGF clinical trials.Ther Adv Musculoskelet Dis. 2023 May 29;15:1759720X231171768. doi: 10.1177/1759720X231171768. eCollection 2023. Ther Adv Musculoskelet Dis. 2023. PMID: 37284331 Free PMC article. Review.
-
Strategic application of imaging in DMOAD clinical trials: focus on eligibility, drug delivery, and semiquantitative assessment of structural progression.Ther Adv Musculoskelet Dis. 2023 Apr 10;15:1759720X231165558. doi: 10.1177/1759720X231165558. eCollection 2023. Ther Adv Musculoskelet Dis. 2023. PMID: 37063459 Free PMC article. Review.
-
Adeno-Associated Virus-Delivered Fibroblast Growth Factor 18 Gene Therapy Promotes Cartilage Anabolism.Cartilage. 2023 Dec;14(4):492-505. doi: 10.1177/19476035231158774. Epub 2023 Mar 6. Cartilage. 2023. PMID: 36879540 Free PMC article.
-
Deep learning applications in osteoarthritis imaging.Skeletal Radiol. 2023 Nov;52(11):2225-2238. doi: 10.1007/s00256-023-04296-6. Epub 2023 Feb 9. Skeletal Radiol. 2023. PMID: 36759367 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical